Ryan Specialty (RYAN) Competitors

Ryan Specialty (NYSE:RYAN) and Manulife Financial (NYSE:MFC) are both large-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, dividends and risk.

Do analysts recommend RYAN or MFC?

Ryan Specialty presently has a consensus price target of $77.30, indicating a potential upside of 32.07%. Manulife Financial has a consensus price target of $47.50, indicating a potential upside of 57.75%. Given Manulife Financial's higher probable upside, analysts plainly believe Manulife Financial is more favorable than Ryan Specialty.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ryan Specialty	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.80
Manulife Financial	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Does the media favor RYAN or MFC?

In the previous week, Manulife Financial had 17 more articles in the media than Ryan Specialty. MarketBeat recorded 36 mentions for Manulife Financial and 19 mentions for Ryan Specialty. Ryan Specialty's average media sentiment score of 0.94 beat Manulife Financial's score of 0.54 indicating that Ryan Specialty is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ryan Specialty	10 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Manulife Financial	13 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation & earnings, RYAN or MFC?

Manulife Financial has higher revenue and earnings than Ryan Specialty. Manulife Financial is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ryan Specialty	$2.81B	5.46	$94.67M	$0.35	167.23
Manulife Financial	$38.90B	1.31	$4.11B	$2.24	13.44

Is RYAN or MFC a better dividend stock?

Ryan Specialty pays an annual dividend of $0.48 per share and has a dividend yield of 0.8%. Manulife Financial pays an annual dividend of $1.28 per share and has a dividend yield of 4.3%. Ryan Specialty pays out 137.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Manulife Financial pays out 57.1% of its earnings in the form of a dividend. Ryan Specialty has increased its dividend for 1 consecutive years and Manulife Financial has increased its dividend for 12 consecutive years. Manulife Financial is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Which has more volatility & risk, RYAN or MFC?

Ryan Specialty has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500. Comparatively, Manulife Financial has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.

Is RYAN or MFC more profitable?

Manulife Financial has a net margin of 10.46% compared to Ryan Specialty's net margin of 6.81%. Ryan Specialty's return on equity of 48.70% beat Manulife Financial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ryan Specialty	6.81%	48.70%	5.59%
Manulife Financial	10.46%	15.77%	0.74%

Do insiders and institutionals have more ownership in RYAN or MFC?

84.8% of Ryan Specialty shares are owned by institutional investors. Comparatively, 52.6% of Manulife Financial shares are owned by institutional investors. 52.2% of Ryan Specialty shares are owned by company insiders. Comparatively, 0.0% of Manulife Financial shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Manulife Financial beats Ryan Specialty on 10 of the 19 factors compared between the two stocks.